Metabolic rewiring in the promotion of cancer metastasis: mechanisms and therapeutic implications
Year: 2020
Type: review
Abstract: Tumor metastasis is the major cause of mortality from cancer. Metabolic rewiring and the metastatic cascade are highly intertwined, co-operating to promote multiple steps of cancer metastasis. Metabolites generated by cancer cells influence the metastatic cascade, encompassing epithelial-mesenchymal transition (EMT), survival of cancer cells in circulation, and metastatic colonization at distant sites. A variety of molecular mechanisms underlie the prometastatic effect of tumor-derived metabolites, such as epigenetic deregulation, induction of matrix metalloproteinases (MMPs), promotion of cancer stemness, and alleviation of oxidative stress. Conversely, metastatic signaling regulates expression and activity of rate-limiting metabolic enzymes to generate prometastatic metabolites thereby reinforcing the metastasis cascade. Understanding the complex interplay between metabolism and metastasis could unravel novel molecular targets, whose intervention could lead to improvements in the treatment of cancer. In this review, we summarized the recent discoveries involving metabolism and tumor metastasis, and emphasized the promising molecular targets, with an update on the development of small molecule or biologic inhibitors against these aberrant situations in cancer.
Source: Oncogene
Authors: Qinyao Wei, Yun Qian, Jun Yu, Chi Chun Wong
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Keywords: cancer metabolism, metabolic reprogramming, metastasis, epithelial-mesenchymal transition, cancer stemness, oxidative stress, matrix metalloproteinases, epigenetic dysregulation, metastatic colonization, circulating tumor cells, metabolic enzymes, small molecule inhibitors, therapeutic target
Open Access status: hybrid
Estimated APC paid: $4,480
Awards: G2218758289, G2561178692, G2783811238, G3117046064, Inhibition of SLC25A22 synergizes with chemotherapy to induce KRAS-mutant colorectal cancer cell death through induction of endoplasmic reticulum stress, Combinatorial blockade of de novo cholesterol biosynthesis and PCSK9 as a synergistic therapy for KRAS-mutant colorectal cancer, Elucidating a novel tumor promoting gene Ring Finger Protein 6 in colorectal cancer, Defining the role of RNA N6-methyladenosine writer methyltransferase like 3 (METTL3) in colorectal cancer, A novel epigenetic therapy for the treatment of KRAS-mutant colorectal cancer
OpenAlex ID: W3081357972
